HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,169 | -17.8% | 35,685 | -11.7% | 0.06% | -11.3% |
Q2 2023 | $1,422 | +218.8% | 40,415 | +195.8% | 0.06% | +195.2% |
Q1 2023 | $446 | -53.4% | 13,665 | -21.4% | 0.02% | -60.4% |
Q4 2022 | $958 | -99.9% | 17,393 | +15.9% | 0.05% | +32.5% |
Q3 2022 | $664,000 | -10.9% | 15,003 | -1.8% | 0.04% | -28.6% |
Q2 2022 | $745,000 | -39.4% | 15,285 | -39.5% | 0.06% | -30.9% |
Q1 2022 | $1,230,000 | – | 25,281 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |